Challenges encountered with argatroban anticoagulation during cardiopulmonary bypass
Use of argatroban as an alternative to heparin during cardiopulmonary bypass (CPB) in patients with heparin-induced thrombocytopenia has gained some attention in the past two decades. Dosing of argatroban during CPB is complex due to lack of complete understanding of its pharmacokinetic profile and...
Main Authors: | Shvetank Agarwal, Beth Ullom, Yasser Al-Baghdadi, Michael Okumura |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
Series: | Journal of Anaesthesiology Clinical Pharmacology |
Subjects: | |
Online Access: | http://www.joacp.org/article.asp?issn=0970-9185;year=2012;volume=28;issue=1;spage=106;epage=110;aulast=Agarwal |
Similar Items
-
Monitoring of argatroban and lepirudin anticoagulation in critically ill patients by conventional laboratory parameters and rotational thromboelastometry – a prospectively controlled randomized double-blind clinical trial
by: Martin Beiderlinden, et al.
Published: (2018-02-01) -
Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland
by: Lorenzo A. Alberio, et al.
Published: (2020-04-01) -
A Prospective Pilot Trial to Assess the Efficacy of Argatroban (Argatra<sup>®</sup>) in Critically Ill Patients with Heparin Resistance <xref rid="fn1-jcm-748765" ref-type="fn">†</xref>
by: Mirjam Bachler, et al.
Published: (2020-03-01) -
Heparin induced thrombocytopenia in pregnancy: A therapeutic challenge case report and literature review
by: Seyyed Mojtaba Nekooghadam, et al.
Published: (2023-08-01) -
An unusual case of bilateral pulmonary embolism in a patient on dual venous thromboprophylaxis, secondary to heparin induced thrombocytopenia
by: Antony Lixon, et al.
Published: (2018-11-01)